- Home
- BNTX vs NTR Comparison
BNTX vs NTR Comparison
Compare BNTX & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- NTR
- Stock Information
- Founded
- BNTX 2008
- NTR 2017
- Country
- BNTX Germany
- NTR Canada
- Employees
- BNTX N/A
- NTR N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- NTR Agricultural Chemicals
- Sector
- BNTX Health Care
- NTR Industrials
- Exchange
- BNTX Nasdaq
- NTR Nasdaq
- Market Cap
- BNTX 25.0B
- NTR 25.5B
- IPO Year
- BNTX 2019
- NTR N/A
- Fundamental
- Price
- BNTX $107.84
- NTR $58.53
- Analyst Decision
- BNTX Strong Buy
- NTR Hold
- Analyst Count
- BNTX 18
- NTR 16
- Target Price
- BNTX $141.55
- NTR $60.63
- AVG Volume (30 Days)
- BNTX 914.5K
- NTR 2.2M
- Earning Date
- BNTX 08-04-2025
- NTR 08-06-2025
- Dividend Yield
- BNTX N/A
- NTR 3.71%
- EPS Growth
- BNTX N/A
- NTR N/A
- EPS
- BNTX N/A
- NTR 1.06
- Revenue
- BNTX $2,968,331,171.00
- NTR $24,739,000,000.00
- Revenue This Year
- BNTX N/A
- NTR $5.84
- Revenue Next Year
- BNTX $10.68
- NTR $2.49
- P/E Ratio
- BNTX N/A
- NTR $55.10
- Revenue Growth
- BNTX 0.61
- NTR N/A
- 52 Week Low
- BNTX $76.53
- NTR $43.70
- 52 Week High
- BNTX $131.49
- NTR $65.08
- Technical
- Relative Strength Index (RSI)
- BNTX 53.44
- NTR 45.32
- Support Level
- BNTX $102.57
- NTR $57.23
- Resistance Level
- BNTX $108.39
- NTR $65.08
- Average True Range (ATR)
- BNTX 2.66
- NTR 1.32
- MACD
- BNTX -0.22
- NTR -0.53
- Stochastic Oscillator
- BNTX 66.59
- NTR 16.56
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About NTR Nutrien Ltd.
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients - nitrogen, potash, and phosphate - although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.